Clinical Trial Update: Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes the outcomes of a Phase 1/2 study evaluating autologous bone marrow-derived mesenchymal stem cell therapy for Type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stem cell therapy

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED